Horizon Pharma plc to Participate in Investor Conferences in November

Horizon Pharma plc to Participate in Investor Conferences in November

11/02/17

DUBLIN, Ireland, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conferences in November:

Stifel 2017 Healthcare Conference

  • Date:  Tuesday, Nov. 14, 2017
  • Presentation Time:  9:30 a.m. EST
  • Location:  New York, NY

Jefferies 2017 London Healthcare Conference

  • Date:  Thursday, Nov. 16, 2017
  • Presentation Time:  2:40 p.m. GMT
  • Location:  London, United Kingdom

Piper Jaffray 29th Annual Healthcare Conference

  • Date:  Tuesday, Nov. 28, 2017
  • Presentation Time:  11:30 a.m. EST
  • Location:  New York, NY

Bank of America/Merrill Lynch 2017 Leveraged Finance Conference

  • Date:  Wednesday, Nov. 29, 2017
  • Presentation Time:  1:30 p.m. EST
  • Location:  Boca Raton, FL

Horizon Pharma’s presentations at these conferences will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcasts will be available for the events.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:                                                                                                 
Tina Ventura                                                                                           
Senior Vice President,                                                                        
Investor Relations                                                                             
investor-relations@horizonpharma.com                                                    

Ruth Venning                                                                                     
Executive Director,                                                                            
Investor Relations                                                                               
investor-relations@horizonpharma.com                                    

U.S. Media:
Geoff Curtis
Senior Vice President, 
Corporate Affairs & Chief Communications Officer
media@horizonpharma.com 

Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie 

Source: Horizon Pharma plc